Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page history shows a new system notice about government funding and a new revision tag (v3.4.1) replacing the previous revision (v3.4.0).
    Difference
    0.8%
    Check dated 2026-02-04T05:35:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows a glossary option and uses color-coded highlights for changes, with a new revision note for v3.4.0; the No FEAR Act data entry was removed and the older v3.3.4 revision is no longer shown.
    Difference
    1.0%
    Check dated 2026-01-28T04:05:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new revision entry: v3.3.4, and removed the previous revision entry: v3.3.3 from the Record History version list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:28:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These are site maintenance metadata changes and do not alter trial data.
    Difference
    0.2%
    Check dated 2025-12-23T10:17:13.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The Record History now lists a new revision tag (v3.3.2) and removes v3.3.1, which is a metadata update to the history log rather than a change to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:09:28.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Version history shows a new revision (v3.3.1) with sponsor naming updated to BeOne Medicines (BeiGene) and status/identification updates. The previous sponsor entry BeiGene and the earlier revision v3.2.0 are listed as deletions.
    Difference
    0.7%
    Check dated 2025-11-24T13:51:54.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.